# Core Laboratories (CLB) — Earnings

CLB · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/clb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.11 |
| EPS estimate | $0.09 |
| EPS surprise | +26.58% |
| Revenue surprise | −1.31% |
| Revenue | $124.6M |
| Revenue estimate | $126.3M |
| Reported | Jul 29, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1958086/000119312526326345/clb-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/a30aa554-b3e6-d1f5-7ed8-badf8cf9ab65.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 29, 2026 | $0.09 | $0.11 | 26.58% | $126.3M | $124.6M |
| Q1 2026 | Apr 29, 2026 | $0.10 | $0.06 | -36.84% | $123.0M | $121.8M |
| Q4 2025 | Feb 4, 2026 | $0.19 | $0.21 | 9.83% | $132.1M | $138.3M |
| Q3 2025 | Oct 22, 2025 | $0.19 | $0.22 | 13.23% | $131.2M | $134.5M |
| Q2 2025 | Jul 23, 2025 | $0.19 | $0.19 | 1.93% | $129.1M | $130.2M |
| Q1 2025 | Apr 23, 2025 | $0.14 | $0.14 | -2.98% | $124.4M | $123.6M |
| Q4 2024 | Jan 29, 2025 | $0.22 | $0.22 | 0.32% | $132.2M | $129.2M |
| Q3 2024 | Oct 23, 2024 | $0.24 | $0.25 | 2.50% | $134.2M | $134.4M |
| Q2 2024 | Jul 24, 2024 | $0.20 | $0.22 | 12.36% | $132.9M | $130.6M |
| Q1 2024 | Apr 24, 2024 | $0.16 | $0.19 | 20.94% | $124.1M | $129.6M |
| Q4 2023 | Jan 31, 2024 | $0.19 | $0.19 | 1.01% | $128.0M | $128.2M |
| Q3 2023 | Nov 1, 2023 | $0.22 | $0.22 | 0.23% | $129.8M | $125.3M |
| Q2 2023 | Jul 26, 2023 | $0.20 | $0.21 | 2.99% | $131.2M | $127.9M |
| Q1 2023 | Apr 26, 2023 | $0.16 | $0.19 | 18.97% | $126.2M | $128.4M |
| Q4 2022 | Feb 1, 2023 | $0.19 | $0.20 | 3.20% | $130.0M | $127.6M |
| Q3 2022 | Oct 26, 2022 | $0.15 | $0.18 | 18.19% | $126.1M | $126.0M |
| Q2 2022 | Jul 27, 2022 | $0.14 | $0.12 | -12.34% | $121.5M | $120.9M |
| Q1 2022 | Apr 27, 2022 | $0.07 | $0.08 | 19.94% | $113.0M | $115.3M |
| Q4 2021 | Feb 2, 2022 | $0.20 | $0.20 | -0.50% | $122.4M | $125.1M |
| Q3 2021 | Oct 27, 2021 | $0.19 | $0.18 | -3.59% | $122.7M | $118.0M |

## Frequently Asked Questions

### When did Core Laboratories (CLB) last report earnings?

Core Laboratories last reported on Jul 29, 2026, covering fiscal Q2 2026.

### Did CLB beat earnings estimates?

Yes. Core Laboratories reported EPS of $0.11 for Q2 2026 against a $0.09 estimate — a 26.58% beat.

### How much revenue did CLB report last quarter?

Core Laboratories reported $124.6M in revenue for Q2 2026, against a consensus estimate of $126.3M.

## Similar Stocks

- [NOV](https://www.lighthorse.io/tickers/nov) — NOV Inc. Common Stock
- [HAL](https://www.lighthorse.io/tickers/hal) — Halliburton Company Common Stock
- [NBR](https://www.lighthorse.io/tickers/nbr) — Nabors Industries Ltd.
- [PTEN](https://www.lighthorse.io/tickers/pten) — Patterson-UTI Energy, Inc. - Common Stock
- [HP](https://www.lighthorse.io/tickers/hp) — Helmerich & Payne, Inc. Common Stock
- [RES](https://www.lighthorse.io/tickers/res) — RPC, Inc. Common Stock
- [WHD](https://www.lighthorse.io/tickers/whd) — Cactus, Inc. Class A Common Stock
- [SLB](https://www.lighthorse.io/tickers/slb) — SLB Limited Common Shares
- [OII](https://www.lighthorse.io/tickers/oii) — Oceaneering International, Inc. Common Stock
- [MGY](https://www.lighthorse.io/tickers/mgy) — Magnolia Oil & Gas Corporation Class A Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).